Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Recruiting · NCT05696782 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2026-09-22 | NCT05696782 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| Wake Forest University Health Sciences | 284 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Atrium Health Levine Cancer | Charlotte | United States | 13 |
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | United States | 26 |